Blog

China restricts export of COVID-19 supplies to approved products only

Arthur Brandwood ,  16 April, 2020

TGA expedites COVID-19 approvals, while keeping up business as usual for other devices

Luis Jimenez ,  2 April, 2020

Expedite! Emergency device regulatory approvals in a pandemic

Arthur Brandwood ,  2 April, 2020

EC Acts Quickly – and issues proposal to delay MDR deadline amidst COVID Pandemic

Luis Jimenez ,  2 April, 2020

Six uncomfortable regulatory truths in a pandemic

Arthur Brandwood ,  25 March, 2020

Getting Shorty – Meeting your obligations for Reporting Medicines Shortages in Australia

Reena Patel ,  24 March, 2020

Keeping the genie in the bottle – managing genetically modified organisms (GMOs) in Australia

Grant Bamde ,  26 February, 2020

2019 US 510(k) Clearances Analysis and FDA’s target to receive innovative technologies first in 2020

Luis Jimenez ,  26 February, 2020

Some Class I Device Transitions Extended – MDR

Grant Bennett ,  3 February, 2020

And out they go…BREXIT is final! But what about Australia?

Grant Bennett ,  30 January, 2020